VNDA Stock Posts

8/21/2026 1:11:16 PM

Unusual Option Volume

VNDA Vanda Pharmaceuticals5.36-0.02 (-0.4%)

Vanda Pharmaceuticals trades 2,558 contracts. The company has the following event: on Dec 12, 2026.

8/5/2026 10:04:59 AM

Upcoming Earnings

VNDA Vanda Pharmaceuticals5.35+0.02 (+0.4%)

Vanda Pharmaceuticals will report earnings after the market closes. View Calendar The market is expecting a ±11.6% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±15.2%. View Expected Move (Conf Call: Aug 5 4:30 PM)

7/16/2026 6:57:20 PM

VNDA #VandaPharmaceuticals stock increases 5.3% after hours.

After Hours Gainer

VNDA Vanda Pharmaceuticals5.45-0.40-6.8%

After Hours:5.74+0.29 (+5.3%)

Vanda Pharmaceuticals Announces EMA Positive Opinion for Orphan Drug Designation of Imsidolimab for Generalized Pustular Psoriasis - A Milestone Recognition of GPP as a Distinct Rare Disease in Europe

PRNewswireThu, 16-Jul 4:30 PM

5/6/2026 10:06:29 AM

Upcoming Earnings

VNDA Vanda Pharmaceuticals7.52+0.13 (+1.8%)

Vanda Pharmaceuticals will report earnings after the market closes. View Calendar The market is expecting a ±9.0% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±12.6%. View Expected Move (Conf Call: May 6 4:30 PM)

5/2/2026 1:50:33 AM

VNDA #VandaPharmaceuticals stock increases 4.0% after hours.

After Hours Gainer

VNDA Vanda Pharmaceuticals7.00-0.10-1.4%

After Hours:7.28+0.28 (+4.0%)

Vanda Pharmaceuticals Announces U.S. Commercial Availability of NEREUS (tradipitant), the First New Pharmacologic Treatment for People with Motion Sickness in More Than 40 Years

PRNewswireFri, 1-May 4:36 PM

5/1/2026 5:08:58 PM

VNDA #VandaPharmaceuticals stock increases 5.1% after hours.

After Hours Gainer

VNDA Vanda Pharmaceuticals7.00-0.10-1.4%

After Hours:7.36+0.36 (+5.1%)